How can ophthalmologists better educate patients about the severity of DME progression?
Kingfisher study: Safety and efficacy of brolucizumab for DME
AAO 2023: Post-hoc analysis of the YOSEMITE and RHINE clinical trials
An overview of the PALADIN study for diabetic macular edema (DME)
AAO 2023: Results of the PHOTON study at 96-weeks
Oxurion NV will file for bankruptcy following KALAHARI data release
Medicines and Healthcare products Regulatory Agency (MHRA) issues UK marketing approval for Biocon Biologics biosimilar aflibercept (YESAFILI)
2 Clarke Drive Cranbury, NJ 08512